Category
-
PR Newswire
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
May 22, 2023 -
Endpoints News
Comanche lines up trial for preeclampsia siRNA with Moderna, Medicines Company vets and GV backing
May 19, 2023 -
Globenewswire
Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
May 19, 2023 -
PR Newswire
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
May 17, 2023 -
PR Newswire
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
May 17, 2023 -
News 12 - New Jersey
be Well: Howie Mandel talks about his OCD diagnosis and what led him to seek help
May 16, 2023 -
Newswire
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
May 16, 2023 -
Business Wire
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 16, 2023 -
Globenewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023 -
Business Wire
CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA
May 15, 2023 -
PR Newswire
Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health
May 15, 2023 -
PR Newswire
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
May 14, 2023 -
PR Newswire
Comanche Biopharma Appoints Allyson Felix to Board of Directors
May 12, 2023 -
Globenewswire
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
May 12, 2023 -
Globenewswire
Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)
May 11, 2023 -
PR Newswire
Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint
May 10, 2023 -
Globenewswire
AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification
May 10, 2023 -
PR Newswire
Doceree forms an exclusive partnership with Hello Health Group to strengthen its global footprint; forays into 8 South East Asian markets
May 10, 2023 -
Fierce Pharma
The most influential people in biopharma in 2023
May 9, 2023 -
Labiotech
Generative AI in novel drug development
May 2, 2023 -
Fierce Healthcare
Eleos Outreach brings AI-enabled click-to-text functionality to field-based clinicians’ EHRs
May 1, 2023 -
Fox News
Students use AI technology to find new brain tumor therapy targets — with a goal of fighting disease faster
May 1, 2023 -
Business Wire
Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting
April 27, 2023 -
PR Newswire
Eleos Advances Behavioral Health AI with Breakthrough Offering for Field Providers
April 27, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 24, 2023 -
Fierce Biotech
AppliedVR’s latest partnership expands covered access to VR therapeutics for veterans, active military
April 24, 2023 -
Business Wire
Bicara Therapeutics Announces Publication in Cancer Research Describing Design and Characterization of Lead Bifunctional Antibody Program, BCA101
April 19, 2023 -
Business Wire
Leyden Labs’ Intranasal PanFlu Antibody Enters the Clinic
April 19, 2023 -
PR Newswire
First-of-its-kind “Global Fertility at Work” Report from Carrot Fertility Reveals Financial Burden and Workplace Stigma are the Biggest Roadblocks to Accessing Fertility and Family-Forming Care
April 18, 2023 -
Endpoints News
Apellis raises uncommon eye disease profile with ‘The Fonz’ actor Henry Winkler
April 17, 2023 -
BBC News Services
How artificial intelligence is matching drugs to patients
April 17, 2023 -
BioPharma Dive
Biogen, aiming for a better Alzheimer’s therapy, licenses a Denali program
April 13, 2023 -
Globenewswire
Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses
April 13, 2023 -
Business Wire
Health Data Cloud Leader 1upHealth Raises $40 Million Series C led by Sixth Street Growth
April 13, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 12, 2023 -
PR Newswire
AppliedVR Partners with Lovell to Better Serve Government Healthcare Systems
April 12, 2023 -
Business Insider
Devoted Health narrowed its losses in 2022, as rival insurance upstarts fought for survival. Now it’s adding members amid a big expansion.
April 11, 2023 -
Business Wire
Firefly Health Launches Advisory Council to Support Business Growth and Product Expansion
April 11, 2023 -
Business Wire
Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
April 6, 2023 -
Business Wire
Bicara Therapeutics to Present Preclinical Data from Clinical-Stage Bifunctional Antibody Program, BCA101, at AACR Annual Meeting 2023
April 4, 2023 -
Authority Magazine
Health Tech: Jake Sattelmair Of Wellframe On How Their Technology Can Make An Important Impact On Our Overall Wellness
April 2, 2023 -
tech.eu
French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment
March 31, 2023 -
Owkin
Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases
March 31, 2023 -
Home Health Care News
How Primary Care Startup Patina Locked Down Partnerships With 4 Big Health Plans
March 30, 2023 -
PR Newswire
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
March 30, 2023 -
Fierce Healthcare
Carrot Fertility expands benefits with hormone replacement therapy coverage
March 29, 2023 -
Boston Globe
Waltham biotech’s vision loss drug helps slow a form of macular degeneration
March 29, 2023 -
Business Wire
TandemAI Announces the Release of TandemViz™ 1.0 Web-based Graphical User Interface for Seamless Integration of Computational Analyses and Experimental Data
March 29, 2023 -
PR Newswire
Marshfield Clinic Health System and Notable Announce System-Wide Deployment of Intelligent Automation to Transform Patient and Staff Engagement
March 27, 2023 -
PR Newswire
AmplifyMD Announces SOC 2 Type 2 Compliance
March 27, 2023 -
PR Newswire
Toku Raises USD $7.15 Million in Seed Round to Revolutionize Subscription Payments in LatAm
March 23, 2023 -
Business Wire
Mental Health Leader SonderMind to Provide More Personalized Care with Acquisition of Mindstrong Technology
March 22, 2023 -
Chronicle
Making health care more accessible with technology
March 21, 2023 -
News Direct
Doceree takes the lead on transparency in programmatic Point-of-Care messaging by championing adoption of IAB standard
March 21, 2023 -
NY Post
AI develops cancer treatment in 30 days, predicts survival rate
March 21, 2023 -
PR Newswire
AppliedVR Becomes First Virtual Reality Provider to Receive HCPCS Level II Code from Centers for Medicare and Medicaid Services as Durable Medical Equipment
March 21, 2023 -
PR Newswire
Benchling Bolsters Success Offerings for Biotech R&D With New Purpose-Built Solutions, Training, and Expert Services
March 21, 2023 -
Business Wire
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
March 20, 2023 -
Business Insider
We got the presentation health-tech veteran Jonathan Bush used to land $40 million for his new startup Zus Health
March 16, 2023 -
PR Newswire
Zus Health Closes Financing, Signs Partnership with Elation Health, to Accelerate Growth of its Data Service to Provide Connective Tissue for Healthcare
March 16, 2023 -
Business Wire
SpectrumAi Secures up to $20M Series A Investment
March 16, 2023 -
PR Newswire
Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023 -
GenomeWeb
New Products Posted to GenomeWeb: Cytek Biosciences, Thermo Fisher Scientific, Bruker
March 10, 2023 -
BioNews, Inc.
AviadoBio acquires rights to gene therapies’ new delivery technology
March 9, 2023 -
Fierce Biotech
Capital Rx CEO: PBM industry needs to be repaired, not ditched
March 9, 2023 -
San Francisco Business Times
Cancer, biosimilar drug maker Coherus shedding more biotech jobs
March 9, 2023 -
Business Wire
CareStack’s All-in-One Dental Software Gets AI Upgrade with Pearl Partnership
March 9, 2023 -
PR Newswire
Centivo Partnership with the Business Health Care Group Reports More Effective Utilization of Health Benefits, Leading to 23 to 36 Percent Cost Savings for Employers and Health Plan Members
March 9, 2023 -
PR Newswire
Capital Rx is Now Part of the B Corp™ Movement, Reinforcing its Commitment to Advancing Equity in Pharmacy Benefits
March 8, 2023 -
Business Wire
James D. Swift, M.D., Elected to Pediatrix Board of Directors
March 8, 2023 -
Globenewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 7, 2023 -
PR Newswire
Capital Rx Named to the Forbes Best Startup Employers 2023 List
March 7, 2023 -
Business Wire
Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
March 6, 2023 -
Business Wire
Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer
March 6, 2023 -
Business Wire
TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
March 1, 2023 -
PR Newswire
Capital Rx Ranks in the Top 50 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies for the Second Year in a Row
February 28, 2023 -
Business Wire
Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
February 28, 2023 -
Globenewswire
Orchard Therapeutics Announces Agreement Enabling Reimbursed Access to Libmeldy for All Eligible MLD Patients in Sweden
February 27, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration
February 27, 2023 -
Business Wire
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
February 27, 2023 -
Business Wire
Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO
February 21, 2023 -
Fast Company
This startup just raised more than half a billion dollars to change how new drugs get discovered
February 19, 2023 -
Fierce Pharma
Apellis wins FDA approval for first geographic atrophy drug
February 17, 2023 -
Globenewswire
Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™
February 15, 2023 -
Fierce Biotech
New biotech VC takes off with $520M and a flight deck stacked with big-name investors ready to serve
February 14, 2023 -
The Guardian
Girl with deadly inherited condition is cured with gene therapy on NHS
February 14, 2023 -
Precision Oncology News
Owkin-led Machine Learning Study IDs Possible Cancer Treatment Biomarkers Using Federated Model
February 14, 2023 -
Globenewswire
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia
February 14, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
February 14, 2023 -
Globenewswire
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023